News from the American Academy of Ophthalmology’s recent annual meeting in Chicago continues to be a hot topic of discussion. This week, we will visit some interesting discussions Sheryl Stevenson and I had with leading KOLs during the conference.
First, let’s take a look at our discussion with Dr. John Berdahl of Vance Thompson Vision, who discusses the clinical trials of travoprost.
Watch: AAO 2024: Clinical trials of travoprost
Next, we discussed Incidence and prevalence of uveitis and associated ocular complications in the US TriNetX Database with Meghan Berkenstockan associate professor of ophthalmology at the Wilmer Eye Institute.
Watch: AAO 2024: Incidence and prevalence of uveitis and associated ocular complications in the US TriNetX Database
We also talked to Dr. Michael Singer, director of clinical research, Medical Center Ophthalmology Associates, shared insights on the results of research on the effectiveness of gel versus traditional drops as anesthesia for intravitreal injections.
Leave a Reply